NEW YORK (TheStreet) -- CHANGE IN RATINGS
Boston Scientific BSX was upgraded at JMP Securities to outperform from market perform. $9 price target. Company is on the cusp of a multiyear growth period, JMP said.
Buenaventura Mining BVN was downgraded to hold at TheStreet Ratings.
Carbo Ceramics CRR was upgraded to buy at TheStreet Ratings.
Cinemark CNK was downgraded at JP Morgan from overweight to neutral. $30 price target. Valuation call, as the stock is up 53% year to date, JP Morgan said.
Deckers Outdoor DECK was upgraded at Sterne Agee from neutral to buy. $65 price target. Business can turn by the second half of 2013, Sterne Agee said.
Dell DELL was upgraded at Goldman Sachs from sell to buy. $13 price target. Solid cash position should help place a floor on the stock, Goldman said.
Edison International EIX was downgraded at Bernstein Research to market perform. Valuation call, based on a $50 price target. Company faces potential growth headwinds, Bernstein said.
Eaton Vance EV was upgraded at Goldman Sachs to neutral from sell. $29.50 price target. Better flow outlook, but valuation still stretched, Goldman said.
Finisar FNSR was upgraded at Needham from hold to buy. $18 price target. Service provider spending should increase over the coming quarters for the company's new products, Needham said.
International Game IGT was upgraded at Deutsche Bank from hold to buy. $19 price target. Worst operating trends are likely behind the company, Deutsche Bank.
Janus Capital Group JNS was downgraded at Goldman Sachs to sell from neutral. $7 price target. Tougher flow outlook not priced in, Goldman said.
Lululemon LULU was initiated with a buy rating at Canaccord Genuity. $91 price target. Company is evolving beyond its athletic roots, Canaccord said.
Occidental Petroleum OXY was downgraded at Deutsche Bank from buy to hold. $80 price target.
PartnerRe PRE was downgraded at UBS to neutral from buy. $84 price target. Valuation call, UBS said.
Bankrate RATE was downgraded at Canaccord Genuity to hold. $14 price target. Company faces tough comps, Canaccord said.
Regal Entertainment RGC was downgraded at JP Morgan from overweight to neutral. Valuation call, as the stock is up 39% year to date, JP Morgan said. $17 price target.
Research In Motion RIMM was downgraded at Canaccord to sell. Valuation call, based on a $10 price target. Core fundamentals remain soft, Canaccord said.
Teva Pharmaceuticals TEVA was downgraded at UBS to neutral from buy. $41 price target. Company's transition will take time, UBS said.
Verizon VZ was upgraded at Nomura from neutral to buy. $50 price target. Company has superior execution and can continue to grow, Nomura said.
Williams-Sonoma WSM was upgraded at Morgan Stanley from equal-weight to overweight. $54 price target. Business is improving and the company can post double-digit annual growth over the next few years, Morgan Stanley said.
Woodward WWD was downgraded at Drexel Hamilton to hold. Valuation call, Drexel said.
STOCK COMMENTS / EPS CHANGES
Albemarle ALB target raised at Jefferies tO $77, Jefferies said. Improvements in end markets. Buy rating.
Ametek AME numbers raised at Jefferies. Shares of AME now seen reaching $44, Jefferies said. Estimates also raised 2013 productivity goal large. Buy rating.
FedEx FDX numbers lowered at Citigroup. Shares of FDX now seen reaching $103, Citigroup said. Estimates also lowered as express headwinds persist. Buy rating.
Huntsman HUN estimates lowered at UBS through 2013, UBS said. Softer 4Q expected by company. Buy rating and $16 price target.
Teva TEVA estimates, target reduced at Credit Suisse. Shares of TEVA now seen reaching $50, according to Credit Suisse. Estimates also cut, given the company's new guidance. Outperform rating.
Thoratec THOR added to Conviction Buy List at Goldman. Estimates also boosted, as the company can gain market share. $48 price target.
Toll Brothers TOL target raised at Citigroup to $34 to reflect peer multiple expansion, Citigroup said. Neutral rating.
>To submit a news tip, email: email@example.com.
READERS ALSO LIKE:
Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE. Sign up today to get e-mail alerts before every trade.